BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang W, Wang H, Sun M, Deng X, Wu X, Ma Y, Li M, Shuoa SM, You Q, Miao L. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Commun (Lond) 2020;40:69-80. [PMID: 32237072 DOI: 10.1002/cac2.12010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Jin L, Kim HS, Shi J. Neutrophil in the Pancreatic Tumor Microenvironment. Biomolecules 2021;11:1170. [PMID: 34439836 DOI: 10.3390/biom11081170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chu YB, Li J, Jia P, Cui J, Zhang R, Kang X, Lv M, Zhang S. Irf1- and Egr1-activated transcription plays a key role in macrophage polarization: A multiomics sequencing study with partial validation. Int Immunopharmacol 2021;99:108072. [PMID: 34426111 DOI: 10.1016/j.intimp.2021.108072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang T, Chen B, Meng T, Liu Z, Wu W. Identification and immunoprofiling of key prognostic genes in the tumor microenvironment of hepatocellular carcinoma. Bioengineered 2021;12:1555-75. [PMID: 33955820 DOI: 10.1080/21655979.2021.1918538] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Clark PA, Sriramaneni RN, Bates AM, Jin WJ, Jagodinsky JC, Hernandez R, Le T, Jeffery JJ, Marsh IR, Grudzinski JJ, Aluicio-Sarduy E, Barnhart TE, Anderson BR, Chakravarty I, Arthur IS, Kim K, Engle JW, Bednarz BP, Weichert JP, Morris ZS. Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain. Radiat Res 2021;195:522-40. [PMID: 33826741 DOI: 10.1667/RADE-20-00237.1] [Reference Citation Analysis]
5 Yang B, Xie J, Li Z, Su D, Lin L, Guo X, Fu Z, Zhou Q, Lu Y. Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer. Gland Surg 2021;10:1397-409. [PMID: 33968691 DOI: 10.21037/gs-21-28] [Reference Citation Analysis]
6 Wang L, Sfakianos JP, Beaumont KG, Akturk G, Horowitz A, Sebra RP, Farkas AM, Gnjatic S, Hake A, Izadmehr S, Wiklund P, Oh WK, Szabo PM, Wind-Rotolo M, Unsal-Kacmaz K, Yao X, Schadt E, Sharma P, Bhardwaj N, Zhu J, Galsky MD. Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing. Clin Cancer Res 2021;27:4287-300. [PMID: 33837006 DOI: 10.1158/1078-0432.CCR-20-4574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ye J, Wang H, Cui L, Chu S, Chen N. The progress of chemokines and chemokine receptors in autism spectrum disorders. Brain Res Bull 2021;174:268-80. [PMID: 34077795 DOI: 10.1016/j.brainresbull.2021.05.024] [Reference Citation Analysis]
8 Zhang S, Ding J, Wang J, Yin T, Zhang Y, Yang J. CXCL5 Downregulation in Villous Tissue Is Correlated With Recurrent Spontaneous Abortion. Front Immunol 2021;12:717483. [PMID: 34603292 DOI: 10.3389/fimmu.2021.717483] [Reference Citation Analysis]
9 Dai L, Li M, Zhang WL, Tang YJ, Tang YL, Liang XH. Fibroblasts in cancer dormancy: foe or friend? Cancer Cell Int 2021;21:184. [PMID: 33771156 DOI: 10.1186/s12935-021-01883-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Nie G, Cao X, Mao Y, Lv Z, Lv M, Wang Y, Wang H, Liu C. Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin. Int Immunopharmacol 2021;95:107153. [PMID: 33677254 DOI: 10.1016/j.intimp.2020.107153] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhang W, Wang H, Sun M, Deng X, Wu X, Ma Y, Li M, Shuoa SM, You Q, Miao L. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Commun (Lond) 2020;40:69-80. [PMID: 32237072 DOI: 10.1002/cac2.12010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
12 Nie Y, Jiang MC, Liu C, Liu Q, Zhu X. CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates. Front Oncol 2021;11:637023. [PMID: 33869023 DOI: 10.3389/fonc.2021.637023] [Reference Citation Analysis]
13 Wan Y, Ge K, Zhou W, Lu J, Jia C, Zhu H. C-X-C chemokine receptor 2 (Cxcr2) promotes hepatocellular carcinoma immune evasion via regulating programmed death-ligand 1 (PD-L1). Biol Chem 2021;402:729-37. [PMID: 33583159 DOI: 10.1515/hsz-2020-0328] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Zhang Y, Zheng S, Liao N, Huang H, Chen W, Wu Z, Wu D. CircCTNNA1 acts as a ceRNA for miR-363-3p to facilitate the progression of colorectal cancer by promoting CXCL5 expression. J Biol Res (Thessalon) 2021;28:7. [PMID: 33640021 DOI: 10.1186/s40709-021-00135-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Sun X, Wang C, Chen C, Huang J, Wu X, Wang Y, He X, Cao J, Jiang W, Sun P, Li Z. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma. Hematol Oncol 2021. [PMID: 34543472 DOI: 10.1002/hon.2926] [Reference Citation Analysis]
16 Caligiuri A, Pastore M, Lori G, Raggi C, Di Maira G, Marra F, Gentilini A. Role of Chemokines in the Biology of Cholangiocarcinoma. Cancers (Basel) 2020;12:E2215. [PMID: 32784743 DOI: 10.3390/cancers12082215] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Luo M, Hu Z, Kong Y, Li L. MicroRNA-432-5p inhibits cell migration and invasion by targeting CXCL5 in colorectal cancer. Exp Ther Med 2021;21:301. [PMID: 33717244 DOI: 10.3892/etm.2021.9732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mo M, Li Y, Hu X. Serum CXCL5 level is associated with tumor progression in penile cancer. Biosci Rep 2021;41:BSR20202133. [PMID: 33458757 DOI: 10.1042/BSR20202133] [Reference Citation Analysis]